|
BCL2L2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.68130000000244E-05 |
| Normal-vs-Stage3 |
9.99200722162641E-16 |
| Normal-vs-Stage4 |
1.63424829224823E-12 |
| Stage1-vs-Stage2 |
1.453960E-02 |
| Stage1-vs-Stage3 |
3.178800E-01 |
| Stage1-vs-Stage4 |
4.890200E-02 |
| Stage2-vs-Stage3 |
4.663100E-03 |
| Stage2-vs-Stage4 |
1.598490E-03 |
| Stage3-vs-Stage4 |
3.644200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.23500000001908E-06 |
| Normal-vs-Asian |
1.70290448409105E-11 |
| Caucasian-vs-AfricanAmerican |
1.922610E-01 |
| Caucasian-vs-Asian |
9.177800E-01 |
| AfricanAmerican-vs-Asian |
2.616000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
6.663500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62536650805123E-12 |
| Normal-vs-Age(41-60Yrs) |
7.7715611723761E-16 |
| Normal-vs-Age(61-80Yrs) |
4.23094892454401E-12 |
| Normal-vs-Age(81-100Yrs) |
6.11589999999218E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.409400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.431600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.010800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.868400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.604800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.081600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.802210E-01 |
| Classical-VS-Follicular |
7.242600E-03 |
| Classical-VS-Other |
3.927200E-01 |
| Classical-VS-Normal |
2.03126404585419E-12 |
| Tall-VS-Follicular |
1.302610E-03 |
| Tall-VS-Other |
8.542000E-01 |
| Tall-VS-Normal |
1.03994590716638E-12 |
| Follicular-VS-Other |
1.573970E-01 |
| Follicular-VS-Normal |
4.66830000001028E-06 |
| Other-VS-Normal |
1.173110E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.44662060108658E-13 |
| Normal-vs-N1 |
5.44009282066327E-15 |
| N0-vs-N1 |
8.876800E-03 |
|
|
